RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro
- 28 February 2009
- journal article
- research article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 27 (4) , 402-411
- https://doi.org/10.1007/s00774-009-0054-x
Abstract
Noggin is a major extracellular antagonist to bone morphogenetic proteins (BMPs) which binds to BMPs and blocks binding of them to BMP-specific receptors and negatively regulates BMP-induced osteoblastic differentiation. In this study, we investigated the effect of noggin silencing by transfection of small interfering RNA (siRNA) on BMP-induced osteoblastic differentiation in vitro and ectopic bone formation in vivo induced by recombinant human BMP-2 (rhBMP-2). Noggin mRNA expression was up-regulated in response to rhBMP-2 in C2C12 cells, a myoblastic cell line, in dose- and time-dependent fashion as determined by real-time RT-PCR assay. Silencing of noggin expression by transfection of noggin siRNA suppressed BMP-stimulated noggin expression, resulting in acceleration of BMP-induced osteoblastic differentiation. For in vivo noggin silencing, siRNA was injected locally into back muscles and transfected into local cells by electroporation, where rhBMP-2-retaining (5 μg) collagen disks had been surgically placed. The implants were harvested at 2 weeks after surgery from experimental and control group mice and analyzed by radiological and histological methods. As a result, bone mineral content of ossicles ectopically induced by rhBMP-2 was significantly increased by silencing of noggin. Our findings suggest that silencing of noggin enhances the osteoblastic differentiation of BMP-responding cells in vitro and new bone formation induced by rhBMP-2 in vivo by eliminating negative regulation of the effects of BMP. RNA interference might be useful for intensifying the effects of BMP in promoting new bone (callus) formation in repair of damaged bone.Keywords
This publication has 34 references indexed in Scilit:
- Heterotopic Bone Formation With the Use of rhBMP2 in Posterior Minimal Access Interbody FusionSpine, 2007
- Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiationBone, 2007
- Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in OsteoclastsCell, 2007
- Noggin Suppression Enhances in Vitro Osteogenesis and Accelerates in Vivo Bone FormationJournal of Biological Chemistry, 2007
- Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2Journal of Biological Chemistry, 2006
- Regulating Bone Growth and Development with Bone Morphogenetic ProteinsAnnals of the New York Academy of Sciences, 2006
- A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2Biochemical and Biophysical Research Communications, 2004
- Retroviral Delivery of Noggin Inhibits the Formation of Heterotopic Ossification Induced by BMP-4, Demineralized Bone Matrix, and Trauma in an Animal ModelJournal of Bone and Joint Surgery, 2004
- Involvement of Phosphodiesterase Isozymes in Osteoblastic DifferentiationJournal of Bone and Mineral Research, 2002
- Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.Journal of Clinical Investigation, 1998